J. Rivera‐Caravaca

发表

Under-prescription of novel antiplatelet drugs in patients with acute coronary syndrome and previous cardiovascular disease.

E. Orenes-Piñero, M. A. Esteve-Pastor, J. Ruiz-Nodar, 2019, Minerva medica.

Reliability and Validity of a Stress Scale in Public Employees from Murcia (Spain)

J. Rivera‐Caravaca, María Teresa Rodríguez-González-Moro, J. I. Gallego-Gómez, 2020, International journal of environmental research and public health.

Low body weight and clinical outcomes in acute coronary syndrome patients: results of the ACHILLES Registry

M. Valdés, E. Orenes-Piñero, M. A. Esteve-Pastor, 2017, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

Adherence to the ‘Atrial Fibrillation Better Care’ Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes—A Systematic Review and Meta-Analysis of 285,000 Patients

G. Lip, J. Rivera‐Caravaca, M. Kozieł, 2021, Thrombosis and Haemostasis.

A new tool to assess patients' comfort during hospitalization: The Hospital Discomfort Risk (HDR) questionnaire.

J. Rivera‐Caravaca, María Teresa Rodríguez-González-Moro, J. I. Gallego-Gómez, 2019, Journal of nursing management.

The COVID-19 Pandemic and Its Impact on Homebound Nursing Students

J. Rivera‐Caravaca, María Teresa Rodríguez-González-Moro, J. I. Gallego-Gómez, 2020, International journal of environmental research and public health.

Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated "Real-World" in Patients With Atrial Fibrillation.

E. Orenes-Piñero, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2018, The American journal of cardiology.

Temporal Changes in Platelet Response in Acute Coronary Syndrome Patients With Prasugrel and Clopidogrel After Stent Implantation.

M. Valdés, E. Orenes-Piñero, A. Tello-Montoliu, 2017, Circulation journal : official journal of the Japanese Circulation Society.

One‐year efficacy and safety of prasugrel and ticagrelor in patients with acute coronary syndromes: Results from a prospective and multicentre ACHILLES registry

E. Orenes-Piñero, M. A. Esteve-Pastor, J. Ruiz-Nodar, 2020, British journal of clinical pharmacology.

Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Focused Review on Oral Anticoagulation

E. Orenes-Piñero, M. A. Esteve-Pastor, A. Tello-Montoliu, 2021, International journal of molecular sciences.

Growth differentiation factor 15 (GDF-15) in cardiovascular diseases: predicting bleeding after cardiac surgery and beyond that!

J. Rivera‐Caravaca, R. López-Gálvez, J. M. Rivera‐Caravaca, 2022, Thrombosis and haemostasis.

Conservatively managed patients with non-ST-segment elevation acute coronary syndrome are undertreated with indicated medicines

M. Valdés, E. Orenes-Piñero, M. A. Esteve-Pastor, 2018, PloS one.

Relationship between temporal rhythm-based classification of atrial fibrillation and stroke: real-world vs. clinical trial

J. Rivera‐Caravaca, G. Lip, W. Ding, 2022, Journal of Thrombosis and Thrombolysis.

Particulate Matter and Temperature: Increased Risk of Adverse Clinical Outcomes in Patients With Atrial Fibrillation.

J. Rivera‐Caravaca, F. Marín, V. Vicente, 2020, Mayo Clinic proceedings.

University of Birmingham Estimated Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants Compared to Optimally Acenocoumarol Anticoagulated ‘Real- World’ in Patients With Atrial Fibrillation

E. Orenes-Piñero, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2018 .

Aalborg Universitet Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated "Real-World" in Patients With Atrial Fibrillation Esteve-Pastor,

E. Orenes-Piñero, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2018 .

Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry

G. Lip, L. Badimón, Á. Cequier, 2018, Thrombosis and Haemostasis.

Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality

G. Lip, M. Valdés, M. A. Esteve-Pastor, 2018, International journal of clinical practice.

Applicability of the modified CHA2DS2-VASc score for stroke risk stratification in Caucasian atrial fibrillation patients.

J. Rivera‐Caravaca, F. Marín, G. Lip, 2017, European journal of internal medicine.

Novel insights in the relationship of gut microbiota and coronary artery diseases

E. Orenes-Piñero, J. Rivera‐Caravaca, F. Marín, 2021, Critical reviews in food science and nutrition.

Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial

M. A. Esteve-Pastor, J. Rivera‐Caravaca, F. Marín, 2017, Thrombosis and Haemostasis.

Chronic Kidney Disease and Third‐Generation P2Y12 Inhibitors Use in Patients With Acute Coronary Syndrome: Impact on the Prognosis at 1 Year

E. Orenes-Piñero, M. A. Esteve-Pastor, J. Ruiz-Nodar, 2018, Journal of clinical pharmacology.

Switching of Oral P2Y12 Inhibitor Treatment in Patients with Acute Coronary Syndrome: Prevalence, Predictors, and Prognosis

E. Orenes-Piñero, M. A. Esteve-Pastor, J. Ruiz-Nodar, 2019, Clinical Drug Investigation.

Temporal Trends in the Use of Antiplatelet Therapy in Patients With Acute Coronary Syndromes

M. Valdés, E. Orenes-Piñero, M. A. Esteve-Pastor, 2018, Journal of cardiovascular pharmacology and therapeutics.

Influence of the matrix type over the concentration of GDF-15

A. Véliz-Martínez, J. Rivera‐Caravaca, F. Marín, 2020, Journal of Investigative Medicine.

Mid-term outcomes of rapid deployment aortic prostheses in patients with small aortic annulus.

J. Rivera‐Caravaca, Joaquín Pérez-Andreu, D. Saura-Espin, 2021, Interactive cardiovascular and thoracic surgery.

Heart Failure and Cardiac Events: Is a Consecutive Measurement of Biomarkers a Simple and Practical Approach?

M. A. Esteve-Pastor, J. Rivera‐Caravaca, M. Esteve-Pastor, 2019, Thrombosis and Haemostasis.

Relationship between temporal rhythm-based classification of atrial fibrillation and stroke: real-world vs. clinical trial

J. Rivera‐Caravaca, G. Lip, W. Ding, 2022, Journal of Thrombosis and Thrombolysis.

Comparison of Aortic Gradient and Ventricular Mass after Valve Replacement for Aortic Stenosis with Rapid Deployment, Sutureless, and Conventional Bioprostheses

M. A. Esteve-Pastor, J. Rivera‐Caravaca, F. Marín, 2021, Cardiology.

MiR-146a Contributes to Thromboinflammation and Recurrence in Young Patients with Acute Myocardial Infarction

E. Orenes-Piñero, A. Véliz-Martínez, J. Rivera‐Caravaca, 2022, Journal of personalized medicine.

Incidence and causes of pacemaker implantation during postoperative period of aortic valve replacement with rapid deployment prosthesis

J. Rivera‐Caravaca, S. Cánovas, J. Garcia-Puente, 2019, Pacing and clinical electrophysiology : PACE.

Characterization of atrial fibrillation in real-world patients: testing the 4S-AF scheme in the Spanish and French cohorts of the EORP-AF Long-Term General Registry.

G. Boriani, L. Fauchier, T. Potpara, 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Efficacy and safety of peri-procedural bridging therapy with low molecular weight heparin in atrial fibrillation patients under vitamin K antagonists

M. A. Esteve-Pastor, J. Rivera‐Caravaca, F. Marín, 2018, QJM : monthly journal of the Association of Physicians.

Quality of oral anticoagulation with vitamin K antagonists in ‘real-world’ patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry

G. Lip, L. Badimón, Á. Cequier, 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Predicting heart failure in atrial fibrillation patients: What about using biomarkers?

J. Rivera‐Caravaca, F. Marín, R. López-Gálvez, 2022, American heart journal.

Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol.

G. Lip, M. Valdés, M. A. Esteve-Pastor, 2018, Clinical therapeutics.

Antithrombotic therapy and clinical outcomes at 1 year in the Spanish cohort of the EORP‐AF Long‐term General Registry

A. Maestre, J. Rivera‐Caravaca, S. Castaño, 2021, European journal of clinical investigation.

Impact of anemia as risk factor for major bleeding and mortality in patients with acute coronary syndrome.

M. Valdés, E. Orenes-Piñero, M. A. Esteve-Pastor, 2019, European journal of internal medicine.

The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort

J. Rivera‐Caravaca, G. Lip, V. Roldán, 2022, Journal of General Internal Medicine.

Relation of the ‘Atrial Fibrillation Better Care (ABC) Pathway’ to the Quality of Anticoagulation in Atrial Fibrillation Patients Taking Vitamin K Antagonists

J. Rivera‐Caravaca, F. Marín, G. Lip, 2022, Journal of personalized medicine.

Adherence to the ‘Atrial Fibrillation Better Care’ Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes—A Systematic Review and Meta-Analysis of 285,000 Patients

G. Lip, J. Rivera‐Caravaca, M. Kozieł, 2021, Thrombosis and Haemostasis.

Should we make the risk stratification process more complex in patients with atrial fibrillation?

G. Lip, J. Rivera‐Caravaca, P. Nielsen, 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Variables affecting the quality of anticoagulation in atrial fibrillation patients newly initiating vitamin K antagonists: insights from the national and multicentre SULTAN registry.

L. Badimón, J. Rivera‐Caravaca, F. Marín, 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry

L. Sposato, C. Macaya, A. Fernández-Ortiz, 2022, International journal of clinical practice.

Hypertension and Atrial Fibrillation: Balancing Stroke and Bleeding Risks.

G. Lip, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2017, American journal of hypertension.

A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry

L. Badimón, Á. Cequier, M. A. Esteve-Pastor, 2022, Expert opinion on pharmacotherapy.

Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study

J. Cosín Sales, V. Barrios, J. Rivera‐Caravaca, 2022, European journal of clinical investigation.

Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in 'real-world' atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients.

G. Lip, M. Valdés, M. A. Esteve-Pastor, 2017, International journal of cardiology.

Validating scores predicting atrial fibrillation recurrence post catheter ablation in patients with concurrent atrial fibrillation and pulmonary diseases.

J. Rivera‐Caravaca, Ying Bai, Yue Liu, 2021, Annals of palliative medicine.

Relationship between multimorbidity and outcomes in atrial fibrillation

L. Badimón, Á. Cequier, M. A. Esteve-Pastor, 2021, Experimental Gerontology.

Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation

J. Rivera‐Caravaca, G. Lip, E. Fazio-Eynullayeva, 2022, Clinical Research in Cardiology.

Non-vitamin K Antagonist Oral Anticoagulants and Drug-Food Interactions: Implications for Clinical Practice and Potential Role of Probiotics and Prebiotics

J. Rivera‐Caravaca, V. Roldán, R. López-Gálvez, 2022, Frontiers in Cardiovascular Medicine.

Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system

J. Rivera‐Caravaca, G. Lip, V. Roldán, 2022, Frontiers in Cardiovascular Medicine.

Letter by Ding et al Regarding Article, "Direct-Acting Oral Anticoagulants Versus Warfarin in Medicare Patients With Chronic Kidney Disease and Atrial Fibrillation".

G. Lip, J. Rivera‐Caravaca, W. Ding, 2020, Stroke.

Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease

J. Rivera‐Caravaca, F. Marín, G. Lip, 2019, Scientific Reports.

Incidence and predictors of sternal surgical wound infection in cardiac surgery: A prospective study

J. Rivera‐Caravaca, F. Gutiérrez-García, E. García-Vázquez, 2022, International wound journal.

A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the “Real‐World” vs Clinical Trials

G. Lip, J. Rivera‐Caravaca, F. Marín, 2018, Mayo Clinic proceedings.

Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation

G. Lip, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2017, Expert opinion on drug safety.

The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal

M. A. Esteve-Pastor, J. Rivera‐Caravaca, F. Marín, 2019, Thrombosis and Haemostasis.

Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores.

G. Lip, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2019, Stroke.

Prediction of Residual Stroke Risk in Anticoagulated Patients with Atrial Fibrillation: mCARS

C. Torp-Pedersen, J. Rivera‐Caravaca, F. Marín, 2021, Journal of Clinical Medicine.

Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project

J. Rivera‐Caravaca, F. Marín, V. Vicente, 2018, Journal of General Internal Medicine.

Apixaban may have lower risk of GI bleeding compared with dabigatran and rivaroxaban in patients with atrial fibrillation

J. Rivera‐Caravaca, G. Lip, 2017, Evidence-Based Medicine.

Predicting Adverse Events beyond Stroke and Bleeding with the ABC-Stroke and ABC-Bleeding Scores in Patients with Atrial Fibrillation: The Murcia AF Project

J. Rivera‐Caravaca, F. Marín, V. Vicente, 2020, Thrombosis and Haemostasis.

Utilizing biomarkers associated with cardiovascular events in atrial fibrillation: informing a precision medicine response

G. Lip, J. Rivera‐Caravaca, F. Marín, 2020 .

Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy

M. A. Esteve-Pastor, J. Rivera‐Caravaca, F. Marín, 2020, Expert Opinion on Pharmacotherapy.

Long‐Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC‐Stroke and CHA 2 DS 2‐VASc Scores

G. Lip, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2017, Journal of the American Heart Association.

Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?

G. Lip, J. Rivera‐Caravaca, F. Marín, 2017, Scientific Reports.

Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews

G. Lip, S. Harrison, J. Rivera‐Caravaca, 2021, European heart journal. Quality of care & clinical outcomes.

A nurse‐led atrial fibrillation clinic: Impact on anticoagulation therapy and clinical outcomes

A. Véliz-Martínez, J. Rivera‐Caravaca, F. Marín, 2020, International journal of clinical practice.

Prediction of long‐term net clinical outcomes using the TIMI‐AF score: Comparison with CHA2DS2‐VASc and HAS‐BLED

G. Lip, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2018, American heart journal.

Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients

G. Lip, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2017, Thrombosis and Haemostasis.

Prediction of long-term net clinical outcomes using the TIMI-AF score : Comparison with CHA 2 DS 2-VASc and HAS-BLED Cover title : Prediction of net clinical outcomes by the TIMI-AF

G. Lip, J. Rivera‐Caravaca, V. Vicente, 2017 .

Manejo inicial del paciente con afectación psiquiátrica en urgencias hospitalarias: revisión sistemática

J. Rivera‐Caravaca, J. I. Gallego-Gómez, A. Simonelli-Muñoz, 2021, Anales del sistema sanitario de Navarra.

Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation.

Á. Cequier, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2017, The American journal of cardiology.

Usefulness of the 2 MACE score to predicts adverse cardiovascular events in patients with atrial fibrillation

Á. Cequier, J. Rivera‐Caravaca, F. Marín, 2017 .

MiR-146a Regulates Neutrophil Extracellular Trap Formation That Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation

J. Rivera‐Caravaca, V. Vicente, N. García-Barberá, 2018, Arteriosclerosis, thrombosis, and vascular biology.

Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus: Results from a Global Federated Health Network Analysis

S. Harrison, D. Lane, J. Rivera‐Caravaca, 2023, Journal of clinical medicine.

Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID‐19

C. Macaya, A. Fernández-Ortiz, I. Nuñez-Gil, 2020, European journal of clinical investigation.

Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes

S. Harrison, J. Rivera‐Caravaca, F. Marín, 2021, Thrombosis Research.

Disparities in the Estimation of Glomerular Filtration Rate According to Cockcroft‐Gault, Modification of Diet in Renal Disease‐4, and Chronic Kidney Disease Epidemiology Collaboration Equations and Relation With Outcomes in Patients With Acute Coronary Syndrome

E. Orenes-Piñero, J. Ruiz-Nodar, A. Véliz-Martínez, 2018, Journal of the American Heart Association.

Gut Microbiota and the Quality of Oral Anticoagulation in Vitamin K Antagonists Users: A Review of Potential Implications

G. Lip, E. Orenes-Piñero, J. Rivera‐Caravaca, 2021, Journal of clinical medicine.

Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA2DS2-VASc and GARFIELD-AF Risk Scores

G. Lip, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2020, Thrombosis and Haemostasis.

Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases

G. Lip, S. Harrison, J. Rivera‐Caravaca, 2021, Cardiovascular Diabetology.

Number needed to treat for net effect of anticoagulation in atrial fibrillation: Real‐world vs. clinical‐trial evidence

G. Lip, Guowei Li, J. Rivera‐Caravaca, 2021, British journal of clinical pharmacology.

Imaging in atrial fibrillation: a way to assess atrial fibrosis and remodeling to assist decision-making.

E. Orenes-Piñero, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2022, American heart journal.

Pilot Study on the Role of Circulating miRNAs for the Improvement of the Predictive Ability of the 2MACE Score in Patients with Atrial Fibrillation

J. Rivera‐Caravaca, F. Marín, V. Vicente, 2020, Journal of clinical medicine.

Factors Affecting the Quality of Anticoagulation With Vitamin K Antagonists in Venous Thromboembolism Patients

J. Rivera‐Caravaca, V. Roldán, Inmaculada Viedma-Viedma, 2017, Biological research for nursing.

Enhancing the ‘real world’ prediction of cardiovascular events and major bleeding with the CHA2DS2-VASc and HAS-BLED scores using multiple biomarkers

M. A. Esteve-Pastor, J. Rivera‐Caravaca, F. Marín, 2018, Annals of medicine.

Clinical implications of different types of dementia in patients with atrial fibrillation: Insights from a global federated health network analysis

S. Harrison, D. Lane, J. Rivera‐Caravaca, 2023, Clinical cardiology.

The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II Cohort

J. Rivera‐Caravaca, G. Lip, V. Roldán, 2022, Journal of General Internal Medicine.

Relationship between sleep habits and academic performance in university Nursing students

J. Rivera‐Caravaca, J. I. Gallego-Gómez, A. Simonelli-Muñoz, 2021, BMC Nursing.

Impact of the COVID-19 pandemic on stress and sleep in emergency room professionals.

J. Rivera‐Caravaca, J. I. Gallego-Gómez, A. Simonelli-Muñoz, 2023, Journal of clinical nursing.

Work Shift and Circadian Rhythm as Risk Factors for Poor Sleep Quality in Public Workers from Murcia (Spain)

J. Rivera‐Caravaca, María Teresa Rodríguez-González-Moro, J. I. Gallego-Gómez, 2020, International journal of environmental research and public health.

Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apnea

E. Orenes-Piñero, J. Rivera‐Caravaca, G. Lip, 2023, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Outcomes in VKA‐treated patients with atrial fibrillation and chronic kidney disease: Clinical trials vs ‘real‐world’

J. Rivera‐Caravaca, F. Marín, G. Lip, 2020, International journal of clinical practice.

Risk factors for the development of incident atrial fibrillation in patients with cardiac implantable electronic devices.

G. Lip, Yoshio Kobayashi, J. Rivera‐Caravaca, 2018, European journal of internal medicine.

Comparative assessment of prophylactic transfusions of platelet concentrates obtained by the PRP or buffy-coat methods, in patients undergoing allogeneic hematopoietic stem cell transplantation

J. Rivera‐Caravaca, V. Vicente, F. de Arriba, 2018, Hematology.

Impact of renal function on Ticagrelor-induced antiplatelet effects in coronary artery disease patients.

A. Tello-Montoliu, J. Rivera‐Caravaca, D. P. Figal, 2023, International journal of cardiology. Heart & vasculature.

Reliability and validity of the student stress inventory-stress manifestations questionnaire and its association with personal and academic factors in university students.

J. Rivera‐Caravaca, J. I. Gallego-Gómez, A. Simonelli-Muñoz, 2018, Nurse education today.

Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients.

G. Lip, F. Violi, M. A. Esteve-Pastor, 2018, Circulation journal : official journal of the Japanese Circulation Society.

Therapeutic management and one-year outcomes in elderly patients with acute coronary syndrome

E. Orenes-Piñero, J. Ruiz-Nodar, V. Pernías-Escrig, 2017, Oncotarget.

Novel biomarkers in Alzheimer’s disease using high resolution proteomics and metabolomics: miRNAS, proteins and metabolites

E. Orenes-Piñero, J. Rivera‐Caravaca, Diana Navas-Carrillo, 2020, Critical reviews in clinical laboratory sciences.

Thoracic aortic aneurysm and atrial fibrillation: clinical associations with the risk of stroke from a global federated health network analysis

R. Akhtar, J. Rivera‐Caravaca, G. Lip, 2023, Internal and Emergency Medicine.

Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?

S. Agewall, J. Rivera‐Caravaca, G. Lip, 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation

M. A. Esteve-Pastor, J. Rivera‐Caravaca, F. Marín, 2019, BMJ Open.

Effectiveness of music therapy and progressive muscle relaxation in reducing stress before exams and improving academic performance in Nursing students: A randomized trial.

J. Rivera‐Caravaca, J. I. Gallego-Gómez, A. Simonelli-Muñoz, 2019, Nurse Education Today.

Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease

J. Rivera‐Caravaca, F. Marín, G. Lip, 2019, Scientific Reports.

Peripheral artery disease: Update on etiology, pathophysiology, diagnosis and treatment.

J. Rivera‐Caravaca, F. Marín, D. Mandaglio-Collados, 2023, Medicina clinica.

Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry.

J. Masjuán, V. Barrios, J. Rivera‐Caravaca, 2022, European Heart Journal - Cardiovascular Pharmacotherapy.

Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation

G. Lip, J. Rivera‐Caravaca, F. Marín, 2017, Scientific Reports.

Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation: A Comparison Between the HAS‐BLED and GARFIELD‐AF Bleeding Scores

G. Lip, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2018, Journal of the American Heart Association.

Prediction of ischemic stroke in different populations: a comparison of absolute stroke risk and CHA2DS2-VASc in real-world and clinical trial patients.

J. Rivera‐Caravaca, G. Lip, W. Ding, 2021, European journal of internal medicine.

Occupational Therapy in Severe Mental Disorder—A Self-Controlled Quasi-Experimental Study

J. Rivera‐Caravaca, J. I. Gallego-Gómez, A. Simonelli-Muñoz, 2022, Healthcare.

Occupational Therapy in the Process of Recovering from Severe Mental Disorder

J. Rivera‐Caravaca, J. I. Gallego-Gómez, A. Simonelli-Muñoz, 2021 .

Epilepsy-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications in patients with Epilepsy.

A. Marson, J. Rivera‐Caravaca, G. Lip, 2023, Current problems in cardiology.

Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment.

J. Rivera‐Caravaca, G. Barón-Esquivias, F. Arribas Ynsaurriaga, 2023, The American journal of cardiology.

Sleep analysis of hospital and out-of-hospital emergency professionals.

J. Rivera‐Caravaca, J. I. Gallego-Gómez, A. Simonelli-Muñoz, 2023, International emergency nursing.

Reducing bleeding risk in patients on oral anticoagulation therapy

J. Rivera‐Caravaca, V. Roldán, M. Esteve-Pastor, 2023, Expert review of cardiovascular therapy.

Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation

G. Lip, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2017, Scientific Reports.

Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial

J. Rivera‐Caravaca, F. Marín, G. Lip, 2017, Thrombosis and Haemostasis.

Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients.

G. Lip, F. Violi, J. Rivera‐Caravaca, 2018, Circulation journal : official journal of the Japanese Circulation Society.

Incident heart failure, arrhythmias and cardiovascular outcomes with sodium‐glucose cotransporter 2 (SGLT2) inhibitor use in patients with diabetes: Insights from a global federated electronic medical record database

L. Fauchier, J. Rivera‐Caravaca, G. Lip, 2022, Diabetes, obesity & metabolism.

Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation

G. Lip, M. A. Esteve-Pastor, J. Rivera‐Caravaca, 2018, European journal of clinical investigation.

Simplified Geleijnse score for identifying chest pain features associated with coronary ischemia.

A. Véliz-Martínez, A. Tello-Montoliu, J. Rivera‐Caravaca, 2023, Heart & lung : the journal of critical care.

University of Birmingham Prediction of long-term net clinical outcomes using the TIMI-AF score:

J. Rivera‐Caravaca, Asunción Esteve-Pastor, PhD Gregory, 2022 .

Patients with atrial fibrillation and common exclusion criteria from clinical trials are at high risk of clinical events: the Murcia AF Project II (MAFP-II) cohort study.

J. Rivera‐Caravaca, V. Roldán, M. Esteve-Pastor, 2024, Internal and emergency medicine.

Clinical and subclinical acute brain injury caused by invasive cardiovascular procedures.

A. Chieffo, E. Navarese, J. Rivera‐Caravaca, 2024, Nature reviews. Cardiology.

Advances in the medical treatment and diagnosis of intracranial hemorrhage associated with oral anticoagulation.

J. Rivera‐Caravaca, V. Roldán, M. Esteve-Pastor, 2024, Expert review of neurotherapeutics.